Cargando…
Anti-Amyloid Therapies for Alzheimer’s Disease and the Amyloid Cascade Hypothesis
Over the past 30 years, the majority of (pre)clinical efforts to find an effective therapy for Alzheimer’s disease (AD) focused on clearing the β-amyloid peptide (Aβ) from the brain since, according to the amyloid cascade hypothesis, the peptide was (and it is still considered by many) the pathogeni...
Autor principal: | Fedele, Ernesto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578107/ https://www.ncbi.nlm.nih.gov/pubmed/37833948 http://dx.doi.org/10.3390/ijms241914499 |
Ejemplares similares
-
The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
por: Ricciarelli, Roberta, et al.
Publicado: (2017) -
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
por: Reitz, Christiane
Publicado: (2012) -
Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis
por: Walton, Chaska C., et al.
Publicado: (2020) -
The Pathogenesis of Alzheimer's Disease: A Reevaluation of the “Amyloid Cascade Hypothesis”
por: Armstrong, R. A.
Publicado: (2011) -
Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges
por: Wu, Tong, et al.
Publicado: (2022)